Jon M. Foster - 30 Jan 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
EVP and COO
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
30 Jan 2023
Net transactions value
-$6,598,814
Form type
4
Filing time
01 Feb 2023, 18:57:52 UTC
Previous filing
23 Feb 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $1,655,040 +24,000 +219% $68.96 34,938 30 Jan 2023 Direct
transaction HCA Common Stock Options Exercise $831,829 +11,955 +34% $69.58 46,893 30 Jan 2023 Direct
transaction HCA Common Stock Tax liability $4,947,202 -19,531 -42% $253.30 27,362 30 Jan 2023 Direct
transaction HCA Common Stock Sale $4,138,480 -16,424 -60% $251.98 10,938 01 Feb 2023 Direct F1
holding HCA Common Stock 48,958 30 Jan 2023 By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
holding HCA Common Stock 48,958 30 Jan 2023 By LCF Trust (Reporting Person, Trustee)
holding HCA Common Stock 19,985 30 Jan 2023 By JMF Family Trust (Spouse, Trustee)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -24,000 -100% $0.000000* 0 30 Jan 2023 Common Stock 24,000 $68.96 Direct F2
transaction HCA Stock Appreciation Right Options Exercise $0 -11,955 -50% $0.000000 11,955 30 Jan 2023 Common Stock 11,955 $69.58 Direct F3
transaction HCA Stock Appreciation Right Award $0 +23,680 $0.000000 23,680 30 Jan 2023 Common Stock 23,680 $253.30 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.10 to $252.08, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.
F3 The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.
F4 The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.